Answers are grounded in this paper and cite their sources.
The rational design of materials that simultaneously enable bioimaging and photodynamic therapy remains challenging because of their incompatible design principles. Herein, we disclose the synthesis of thermally activated delayed fluorescence copolymers and the development of their polymer dots, which enable both bioimaging and photodynamic therapy without additional photosensitizing segments. The copolymers incorporate a conformationally adaptive donor−π–acceptor architecture (donor = phenoxazine, π = xanthene, and acceptor = dibenzo[a,j]phenazine) as the emissive core, providing efficient orange-to-red thermally activated delayed fluorescence emission via through-space charge transfer, while effectively suppressing severe aggregation-caused quenching, even at emitter loadings as high as 15 mol %. Photophysical studies reveal that the hydrophobic copolymer possesses an extremely narrow singlet–triplet energy gap, favoring efficient intersystem crossing and reverse intersystem crossing. The formulated polymer dots, prepared either with or without a biocompatible surfactant, retain bright orange delayed fluorescence in water and exhibit efficient cellular uptake with minimal cytotoxicity. Furthermore, the polymer dots enable lysosome-targeted cellular imaging and photodynamic therapy, exhibiting a singlet oxygen generation quantum yield of 66% under white-light irradiation. Collectively, these findings highlight a promising strategy for the development of through-space charge-transfer thermally activated delayed fluorescence-based polymer dots for multifunctional nanotheranostic applications.
No takes yet. Share an insight, caveat, or question.
Aota et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: